ASND - Ascendis Pharma A/S

QQQ $ 612.14 $ 1.56 (0.26 %)

DIA $ 470.45 $ 1.64 (0.35 %)

SPY $ 672.31 $ 2.95 (0.44 %)

TLT $ 89.45 $ -0.19 (-0.21 %)

GLD $ 367.77 $ 0.35 (0.1 %)

Previous Close

$ 197.74

Open

$ 200.00

Bid

$ 195.00 x 52

Ask

$ 208.00 x 15

Day's Range

$ 195.80 - $ 202.41

52 Week Range

$ 118.03 - $ 216.45

Volume

316,415

Average Volume

Market Cap

12B

Beta (5Y Monthly)

$ 0.77

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
No Data found

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Ascendis Pharma Announces New Pooled Analy...
11/07/2025 13:38:36

Ascendis Pharma A/S (NASDAQ:ASND) today announced that a new pooled analysis showed sustained and clinically meaningful improve...

Ascendis Pharma To Present Three-Year Data...
11/03/2025 21:04:26

Ascendis Pharma A/S (NASDAQ:ASND) today announced that its data showing sustained improvements in renal function, continued nor...

Here's How Much You Would Have Made Owning...
10/29/2025 15:01:48

Looking Into Ascendis Pharma AS's Recent S...
10/21/2025 17:00:39

Raymond James Initiates Coverage On Ascend...
10/17/2025 15:32:22

Raymond James analyst Martin Auster initiates coverage on Ascendis Pharma (NASDAQ:ASND) with a Strong Buy rating and announc...

Cantor Fitzgerald Maintains Overweight on ...
10/13/2025 13:37:25

Cantor Fitzgerald analyst Li Watsek maintains Ascendis Pharma (NASDAQ:ASND) with a Overweight and raises the price target fr...

JP Morgan Maintains Overweight on Ascendis...
10/09/2025 12:50:01

JP Morgan analyst Jessica Fye maintains Ascendis Pharma (NASDAQ:ASND) with a Overweight and raises the price target from $26...

Ascendis Pharma Submits Marketing Authoris...
10/08/2025 20:03:36

COPENHAGEN, Denmark, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (NASDAQ:ASND) today announced it has submitted a Mar...

What Does the Market Think About Ascendis ...
09/29/2025 17:00:52

Ascendis Pharma AS's (NYSE: ASND) short interest as a percent of float has fallen 14.63% since its last report. According t...

$100 Invested In Ascendis Pharma 10 Years ...
09/25/2025 23:00:33

Ascendis Pharma (NASDAQ: ASND) has outperformed the market over the past 10 years by 13.64% on an annualized basis producing an...

PTC Therapeutics Could Challenge BioMarin ...
09/08/2025 17:56:24

BioMarin's Palynziq significantly lowered blood phenylalanine in teens with PKU, with nearly half reaching target levels in...

$100 Invested In Ascendis Pharma 10 Years ...
09/08/2025 14:15:19

Here's How Much $100 Invested In Ascendis ...
09/04/2025 20:30:39

Ascendis To Present Latest Achondroplasia ...
09/02/2025 20:02:54

B of A Securities Maintains Buy on Ascendi...
09/02/2025 15:41:07

B of A Securities analyst Tazeen Ahmad maintains Ascendis Pharma (NASDAQ:ASND) with a Buy and raises the price target from $...

How Do Investors Really Feel About Ascendi...
08/28/2025 17:00:46

If You Invested $1000 In This Stock 10 Yea...
08/19/2025 15:00:31

JP Morgan Maintains Overweight on Ascendis...
08/19/2025 14:17:08

JP Morgan analyst Jessica Fye maintains Ascendis Pharma (NASDAQ:ASND) with a Overweight and raises the price target from $25...

Citigroup Maintains Buy on Ascendis Pharma...
08/08/2025 22:47:08

Citigroup analyst David Lebowitz maintains Ascendis Pharma (NASDAQ:ASND) with a Buy and raises the price target from $243 to...

RBC Capital Maintains Outperform on Ascend...
08/08/2025 17:22:18

RBC Capital analyst Luca Issi maintains Ascendis Pharma (NASDAQ:ASND) with a Outperform and raises the price target from $21...